nDatalyze Terminates Deal With Prism Diversified Deal After Deadline Passes
nDatalyze terminated its deal with Prism Diversified after the closing deadline passed.
Related stories
Digital Realty and Goodman Seek Nearly 10% Stake in NextDC
NextDC said Digital Realty Trust and Goodman Group teamed up in an attempt to buy nearly 10% of its stock.
M impact | MNA | Nov 04, 2026, 11:48 PM UTC
AstraZeneca reportedly makes an offer for Rhythm Pharmaceuticals
According to some sources, AstraZeneca has made an offer for the obesity-drug maker.
M impact | MNA | Nov 04, 2026, 10:56 PM UTC
Evommune Licenses Hinova Autoimmune Drug in Deal Worth Up to $1.1 Billion
Evommune said it licensed rights to an experimental autoimmune disease treatment from China's Hinova Pharmaceuticals, with up to about $1.1 billion in milestone payments.
M impact | MNA | Nov 04, 2026, 10:24 PM UTC
AstraZeneca Offers for Rhythm, Sources Say
AstraZeneca made an offer for Rhythm, according to sources.
M impact | MNA | Nov 04, 2026, 10:20 PM UTC
Dover Completes Acquisition of Leistung Engineering
Dover completed its acquisition of Leistung Engineering on November 4, 2026.
M impact | MNA | Nov 04, 2026, 10:10 PM UTC
Agility Robotics, Churchill Capital XI Complete Business Combination
Agility Robotics completed its business combination with Churchill Capital Corp XI.
M impact | MNA | Nov 04, 2026, 09:32 PM UTC